Attached files

file filename
8-K - FORM 8-K - Inspyr Therapeutics, Inc.v330187_8k.htm

 

EXHIBIT 16.1

 

RBSM LLP

New York, NY

 

December 12, 2012

 

Securities and Exchange Commission

100 F Street, N.W.

Washington, DC 20549-7561

 

Dear Sirs/Madams:

 

We have read Item 4.01 of Genspera, Inc. (the “Company”) Form 8-K dated December 12, 2012, and are in agreement with the statements relating only to RBSM LLP contained therein. We have no basis to agree or disagree with other statements of the Company contained therein

 

Very truly yours,

 

 

S/S RBSM LLP